Discovery and in vitro characterization of a human anti-CD36 scFv
IntroductionCD36 is a membrane receptor that participates in the cellular uptake of fatty acids and lipid metabolism. CD36 overexpression favors progression of different pathologies, such as atherosclerosis and cancer. Thus, CD36 targeting has medicinal relevance. Herein, we aimed to identify human...
Saved in:
| Main Authors: | Cecilia Mata-Cruz, Sandra L. Guerrero-Rodríguez, Keyla Gómez-Castellano, Gregorio Carballo-Uicab, Juan Carlos Almagro, S. Mayra Pérez-Tapia, Marco A. Velasco-Velázquez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1531171/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
“Stapling” scFv for multispecific biotherapeutics of superior properties
by: Lauren E. Boucher, et al.
Published: (2023-12-01) -
Single-step colony assay with autoinduction of scFv expression for the screening of antibody libraries
by: Mieko Kato, et al.
Published: (2019-04-01) -
Cost-effective production process of scFv antibody fragments against Shiga toxin 2 via recombinant E. coli
by: Marcela Guimarães, et al.
Published: (2025-01-01) -
Integrating Biochemical and Computational Approaches Reveal Structural Insights in Trastuzumab scFv-Fc Antibody Engineering
by: Olga Bednova, et al.
Published: (2025-04-01) -
Neospora caninum as delivery vehicle for anti-PD-L1 scFv-Fc: A novel approach for cancer immunotherapy
by: Clément Riviere, et al.
Published: (2025-06-01)